Cargando…
Novel Mutation in the SLC19A2 Gene in an Iranian Family with Thiamine-Responsive Megaloblastic Anemia: A Series of Three Cases
Thiamine-responsive megaloblastic anemia (TRMA) is a clinical triad characterized by megaloblastic anemia, non-autoimmune diabetes mellitus, and sensory-neural hearing loss. Mutations in the thiamine transporter gene, solute carrier family 19, member 2 (SLC19A2), have been associated with TRMA. Thre...
Autores principales: | Ghaemi, Nosrat, Ghahraman, Martha, Abbaszadegan, Mohammad Reza, Baradaran-Heravi, Alireza, Vakili, Rahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814536/ https://www.ncbi.nlm.nih.gov/pubmed/24072090 http://dx.doi.org/10.4274/Jcrpe.969 |
Ejemplares similares
-
Identification of a SLC19A2 nonsense mutation in Persian families with thiamine-responsive megaloblastic anemia
por: Setoodeh, Aria, et al.
Publicado: (2013) -
Cochlear implant and thiamine-responsive megaloblastic anemia syndrome
por: Hagr, Abdulrahman Abdullah
Publicado: (2014) -
Dyserythropoiesis and myelodysplasia in thiamine‐responsive megaloblastic anemia syndrome
por: Faraji‐Goodarzi, Mojgan, et al.
Publicado: (2020) -
Stroke as an Initial Manifestation of Thiamine-Responsive Megaloblastic Anemia
por: Madaan, Priyanka, et al.
Publicado: (2020) -
Novel DNA variation of GPR54 gene in familial central precocious puberty
por: Ghaemi, Nosrat, et al.
Publicado: (2019)